Skip to Content Skip to Content

Health Sciences

Reset All Filters
2001 Results
$4.6 Million Renewal from NIH to Penn Program that Aims to Diversify Biomedical Education

$4.6 Million Renewal from NIH to Penn Program that Aims to Diversify Biomedical Education

Yvonne Paterson, PhD, professor of Microbiology, at the Perelman School of Medicine, and professor and associate dean, at the School of Nursing, has been awarded an almost $5 million renewal by the National Institute for General Medical Sciences for the U

Karen Kreeger

Composite Nanofibers Developed by Penn Scientists Next Chapter in Orthopaedic Biomaterials

Composite Nanofibers Developed by Penn Scientists Next Chapter in Orthopaedic Biomaterials

Bioengineered replacements for tendons, ligaments, the meniscus of the knee, and other tissues require re-creation of the exquisite architecture of these tissues in three dimensions. These fibrous, collagen-based tissues located throughout the body have an ordered structure that gives them their robust ability to bear extreme mechanical loading.

Karen Kreeger

NIH Awards $18.5 Million to Personalized Therapeutics Consortium Led by Penn Researcher

NIH Awards $18.5 Million to Personalized Therapeutics Consortium Led by Penn Researcher

PHILADELPHIA — The National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI) awarded $18.5 million to establish the Personalized NSAID Therapeutics Consortium (PENTACON), an international group of scientists led by Garret A.

Karen Kreeger

Penn and Novartis Form Alliance to Expand Use of Personalized T Cell Therapy for Cancer Patients

Penn and Novartis Form Alliance to Expand Use of Personalized T Cell Therapy for Cancer Patients

PHILADELPHIA — In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.

Holly Auer